Ingrid Herr
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- MicroRNA in disease regulation
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Cell death mechanisms and regulation 27
- Genomics, phytochemicals, and oxidative stress 19
- RNA Interference and Gene Delivery 18
-
- MicroRNA in disease regulation 16
- Co-authors
- Klaus‐Michael Debatin (35 shared papers)Claudia Friesen (7 shared papers)Markus W. Büchler (20 shared papers)Peter H. Krammer (6 shared papers)Peter Angel (12 shared papers)Jury Gladkich (32 shared papers)Irmela Jeremias (5 shared papers)Anja Apel (5 shared papers)
- Journals
- International Journal of Cancer (13 papers)Cancer Letters (11 papers)Blood (10 papers)International Journal of Oncology (6 papers)Cell Death and Disease (5 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Ingrid Herr
138 papers receiving 10.3k citations
Ingrid Herr's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 2.0k
- Oncology 2.8k
- Molecular Biology 6.4k
- Immunology 1.7k
- Toxicology 216
Countries citing papers authored by Ingrid Herr
This map shows the geographic impact of Ingrid Herr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Herr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Herr more than expected).
Fields of papers citing papers by Ingrid Herr
This network shows the impact of papers produced by Ingrid Herr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Herr. The network helps show where Ingrid Herr may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingrid Herr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells Hit paper breakdown → | 1996 | 904 |
| 2 | Cellular stress response and apoptosis in cancer therapy Hit paper breakdown → | 2001 | 697 |
| 3 | ATF‐2 is preferentially activated by stress‐activated protein kinases to mediate c‐jun induction in response to genotoxic agents. Hit paper breakdown → | 1995 | 566 |
| 4 | 2008 | 461 | |
| 5 | The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. | 1997 | 416 |
| 6 | 1999 | 382 | |
| 7 | 2008 | 350 | |
| 8 | 2010 | 283 | |
| 9 | 1997 | 262 | |
| 10 | 1998 | 244 | |
| 11 | 2008 | 200 | |
| 12 | 2010 | 194 | |
| 13 | 1998 | 193 | |
| 14 | 2010 | 182 | |
| 15 | 1997 | 179 | |
| 16 | Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. | 2003 | 171 |
| 17 | 2012 | 163 | |
| 18 | 2000 | 144 | |
| 19 | 2009 | 136 | |
| 20 | 2009 | 134 |
About Ingrid Herr
Ingrid Herr is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Genetics, having authored 139 papers that have together received 10.6k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (27 papers), Cancer Cells and Metastasis (19 papers), Genomics, phytochemicals, and oxidative stress (19 papers), RNA Interference and Gene Delivery (18 papers), MicroRNA in disease regulation (16 papers), Pancreatic and Hepatic Oncology Research (14 papers), Virus-based gene therapy research (9 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.8k citations), Molecular Biology (6.4k citations), Immunology (1.7k citations) and Toxicology (216 citations). Ingrid Herr has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Klaus‐Michael Debatin, Claudia Friesen, Markus W. Büchler, Peter H. Krammer, Peter Angel, Jury Gladkich, Irmela Jeremias, Anja Apel, Hans van Dam and Gerhard Moldenhauer. Their work appears in journals such as International Journal of Cancer, Cancer Letters, Blood, International Journal of Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.